Susquehanna Fundamental Investments, LLC Haemonetics Corp Transaction History

Susquehanna Fundamental Investments, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$80.84 - $89.45 $2.83 Million - $3.13 Million	-35,032 Reduced 55.71%	27,850 $2.37 Million
Q1 2023 May 16, 2023	SELL	$72.75 - $90.6 $806,870 - $1 Million	-11,091 Reduced 14.99%	62,882 $5.2 Million
Q3 2022 Nov 14, 2022	BUY	$63.3 - $78.66 $264,973 - $329,270	4,186 Added 6.0%	73,973 $5.48 Million
Q1 2022 May 16, 2022	SELL	$43.77 - $63.22 $199,591 - $288,283	-4,560 Reduced 6.13%	69,787 $4.41 Million
Q4 2021 Feb 14, 2022	BUY	$49.55 - $74.59 $1.43 Million - $2.16 Million	28,910 Added 63.63%	74,347 $3.94 Million
Q3 2021 Nov 15, 2021	BUY	$57.6 - $70.59 $2.09 Million - $2.56 Million	36,308 Added 397.72%	45,437 $3.21 Million
Q2 2021 Aug 11, 2021	SELL	$51.81 - $118.56 $290,032 - $663,698	-5,598 Reduced 38.01%	9,129 $608,000
Q1 2021 May 17, 2021	BUY	$111.01 - $139.48 $1.63 Million - $2.05 Million	14,727 New	14,727 $1.64 Million

334

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.54B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.